logo
The FDA Is Warning Shoppers About This Aldi Cheese Recalled From Ohio And 3 Other States

The FDA Is Warning Shoppers About This Aldi Cheese Recalled From Ohio And 3 Other States

Yahoo21-03-2025

The U.S. Food and Drug Administration recently got involved with a voluntary Aldi cheese recall. In February, Great Lakes Cheese Co. Inc. initiated a recall of Aldi's Happy Farms Colby Jack cheese for the potential unintended presence of stainless steel fragments. But as of March 19, the recall was upgraded to the FDA's Class II categorization, indicating that exposure to the fragments carries little chance of "serious adverse health consequences," but may still "cause temporary or medically reversible adverse health consequences," per the FDA website.
The recall affects 12 oz., flexible plastic stand-up pouches of finely shredded Colby Jack cheese from Happy Farms by Aldi, with batch number 8679653 and item number 170374. The recalled cheese also has the UPC code 4061463330840, and best-by dates between July 13 and July 14, 2025.
The potentially contaminated cheese was sold exclusively by Aldi in only four states: Connecticut, Michigan, Ohio, and Pennsylvania. Aldi customers who bought Happy Farms Colby Jack from outside one of these four states should be in the clear.
Read more: Ranking 12 Grocery Store Hot Dogs From Worst To Best
Stainless steel fragments like those that could potentially contaminate the affected cheese should not be eaten. When swallowed, even tiny pieces of stainless steel pose an injury risk from the second they enter your mouth, all the way through your digestive system. As the FDA indicated, severe injury is unlikely, which is why this has not reached a class I recall. Although small cuts in the esophagus from stainless steel fragments might not be considered "serious adverse health consequences," it's a painful and potentially bloody annoyance that's best avoided.
If you have the recalled cheese at home, do not eat it. You can either return the cheese with proof of purchase to your local Aldi for a refund or simply throw away the cheese. Luckily, shoppers seeking a new bag of Happy Farms Colby Jack should be in the clear since this initial recall is weeks old and Aldi long ago removed any affected products from its shelves.
Unfortunately for Aldi, this is not the only recent recall it's weathered. The grocer was the center of several listeria-related recalls at the end of 2024 -- one of which also targeted cheese. But the limited exposure of these affected products, and minimal risk of serious injury, should help keep it from joining the ranks of recalls that will forever haunt Aldi.
Hungry for more? Sign up for the free Daily Meal newsletter for delicious recipes, cooking tips, kitchen hacks, and more, delivered straight to your inbox.
Read the original article on The Daily Meal.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

TransCon® hGH Boosts TransCon® CNP Results in Kids with Achondroplasia by Week 26
TransCon® hGH Boosts TransCon® CNP Results in Kids with Achondroplasia by Week 26

Yahoo

time32 minutes ago

  • Yahoo

TransCon® hGH Boosts TransCon® CNP Results in Kids with Achondroplasia by Week 26

Ascendis Pharma A/S (NASDAQ:ASND) is among the 13 Biotech Stocks with Huge Upside Potential. It reported interim Week 26 data from its Phase 2 COACH Trial, confirming that combining TransCon hGH (lonapegsomatropin) with TransCon CNP (navepegritide) raised annualized growth velocity (AGV) and height Z-scores in children with achondroplasia. A close-up view of a hand manipulating a syringe while delivering TransCon CNP into a tumor. A mean AGV of 9.14 cm/year and a +0.53 Z-score rise were attained by treatment-naïve youngsters (N=12). Children (N=9) treated with TransCon CNP in the past achieved an AGV of 8.25 cm/year with a +0.44 Z-score improvement. The majority of side effects were modest, and safety remained consistent with monotherapies. The COACH Trial is the first to assess this combination in kids between the ages of two and eleven. While TransCon CNP is undergoing FDA priority review, TransCon hGH is approved as SKYTROFA® for juvenile growth hormone insufficiency. The treatment focuses on the FGFR3-CNP signaling imbalance that is at the heart of achondroplasia, a disorder that affects more than 250,000 people worldwide. It is anticipated that the results of week 52 and a scheduled Phase 3 trial in Q4 2025 will further clarify efficacy and long-term benefits. The biopharmaceutical business Ascendis Pharma A/S (NASDAQ:ASND) uses its TransCon technology platform to significantly improve patient outcomes. While we acknowledge the potential of ASND as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025. Disclosure. None.

Enoki Mushrooms Recalled Nationwide for Potential Listeria Contamination—Here's What to Know
Enoki Mushrooms Recalled Nationwide for Potential Listeria Contamination—Here's What to Know

Yahoo

time39 minutes ago

  • Yahoo

Enoki Mushrooms Recalled Nationwide for Potential Listeria Contamination—Here's What to Know

If you've recently grabbed some enoki mushrooms, you'll want to check your fridge. Packages of Enoki mushrooms from Hofood99 Inc. have been recalled by the FDA due to potential contamination with Listeria. The mushrooms that were recalled were sold nationwide and packaged in green plastic. They were in a 200-gram package with a UPC Barcode 6 976532 310051 on the back label, distributed by Hofood99 Inc., 21903 56th Ave., Oakland Gardens, NY 11364. Related: Are Food Recalls Really on the Rise? A Food Microbiologist Weighs In So far, no illnesses have been reported in relation to the mushrooms, but Listeria monocytogenes is a common cause of food safety recalls. Listeria can cause high fevers, severe headache, stiffness, nausea, and diarrhea in healthy people—but infection with listeria can cause stillbirth or miscarriage in pregnant women, and deadly infections in young children, the elderly, and people with weakened immune systems. Related: How to Wash Every Type of Mushroom So They're Safe to Eat If you have the affected products, do not eat them. You can destroy the mushrooms or return them to the store for a full refund. If you have any questions, you can contact Hofood99 at 917-756-9833, between 9 a.m. and 2 p.m., Monday to Friday. Read the original article on Real Simple

Illinois becomes first state to require that all insurance covers Alzheimer's treatment
Illinois becomes first state to require that all insurance covers Alzheimer's treatment

Yahoo

time39 minutes ago

  • Yahoo

Illinois becomes first state to require that all insurance covers Alzheimer's treatment

SPRINGFIELD, Ill. (WCIA) — Illinois is making a major expansion in patient care and access to new treatment for Alzheimer's, thanks to a new state law taking effect in July 2025. Gov. J.B. Pritzker signed a bill that will require state health insurance to cover U.S. Food and Drug Administration (FDA) approved medicine to slow down Alzheimer's and other related diseases. SEE ALSO: New Illinois laws and tax changes set to kick in on July 1, 2025 Some Alzheimer's patients will no longer have to go through step therapy — a process where insurers require patients to try and test less expensive drugs before covering the actual medication prescribed by their doctor. The Alzheimer's Association Illinois Chapter, which has been a forefront advocate for this, called the law 'groundbreaking.' 'For people living with Alzheimer's, slowing the progression of the disease changes someone's life — not only that individual's life, but the lives of their caregivers and all those around them, family and friends,' said David Olson, Director of State Affairs at the Alzheimer's Association Illinois Chapter. This coverage will also include diagnostic testing at the doctor's request. This ensures patients can access an accurate diagnosis before even starting the treatment. In 2020, there were 230,000 seniors with Alzheimer's disease or a related dementia in the state, and according to the Illinois Department of Health, that number is expected to increase to 260,000 this year. With the rise in medical costs, insurance coverage is essential for most families. Bill creating Office of State Public Defender heads to Pritzker's desk The bill's sponsor in the House, Rep. Mary Gill (D-Chicago), said with dementia, time is always at the essence. 'When it comes to slowing Alzheimer's and other dementias, every moment counts,' Gill said. 'We can't waste time on insurance gimmicks like step therapy to save a few bucks, which is why I'm thankful for the strong advocacy and bipartisan support this legislation received.' Other private insurance plans will also begin covering FDA-approved treatment starting in 2027. 'We worked collaboratively with the insurance industry on this legislation,' Olson said. 'We were able to find and agree upon language here that expands access in a way that also isn't increasing cost to consumers.' Currently, there are two types of treatments for Alzheimer's approved by the FDA. One is Lecanemab, and the other is Donanemab. These will not end the disease, as there is currently no cure for Alzheimer's. This law makes Illinois the first state to require such treatment, and advocates said they hope other states will follow its lead. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store